Cargando…
Advanced Biomaterials for Cell‐Specific Modulation and Restore of Cancer Immunotherapy
The past decade has witnessed the explosive development of cancer immunotherapies. Nevertheless, low immunogenicity, limited specificity, poor delivery efficiency, and off‐target side effects remain to be the major limitations for broad implementation of cancer immunotherapies to patient bedside. En...
Autores principales: | Ruan, Shaobo, Huang, Yuanyu, He, Mei, Gao, Huile |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9165523/ https://www.ncbi.nlm.nih.gov/pubmed/35343112 http://dx.doi.org/10.1002/advs.202200027 |
Ejemplares similares
-
Advanced biomaterials for cancer immunotherapy
por: Yang, Fan, et al.
Publicado: (2020) -
Intestinal Bacteria Encapsulated by Biomaterials Enhance Immunotherapy
por: Liu, Yilun, et al.
Publicado: (2021) -
Rethinking CRITID Procedure of Brain Targeting Drug Delivery: Circulation, Blood Brain Barrier Recognition, Intracellular Transport, Diseased Cell Targeting, Internalization, and Drug Release
por: Ruan, Shaobo, et al.
Publicado: (2021) -
Engineered biomaterials for cancer immunotherapy
por: Cai, Lulu, et al.
Publicado: (2020) -
Supramolecular Biomaterials for Cancer Immunotherapy
por: Liang, Huan, et al.
Publicado: (2023)